Vivos Therapeuticsinc Stock In The News
| VVOS Stock | USD 2.72 0.06 2.26% |
The tone or emotional content of news articles related to Vivos TherapeuticsInc can affect its prices. Positive news sentiment can lead to an increase in demand for Vivos TherapeuticsInc's stock, while negative news sentiment can lead to a decrease in demand. Our overall analysis of Vivos TherapeuticsInc's news coverage and content from conventional and social sources shows investors' bearish mood towards Vivos TherapeuticsInc. The specific impact of Vivos TherapeuticsInc news on its stock price will depend on a range of factors, including the nature and significance of the news report and investors' perceptions of Vivos TherapeuticsInc's overall financial health and prospects. It also depends on the type and quality of a news publisher.
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using Vivos TherapeuticsInc headlines in addition to utilizing other, more conventional financial analysis modules. Check out Vivos TherapeuticsInc Backtesting and Vivos TherapeuticsInc Hype Analysis. For more information on how to buy Vivos Stock please use our How to Invest in Vivos TherapeuticsInc guide.
Vivos |
Vivos TherapeuticsInc Today Top News and Investor Outlook
Vivos TherapeuticsInc Past News Timeline
Popular news outlets such as MarketWatch, Bloomberg, or Reuters provide Vivos and other traded companies coverage. We help investors stay connected with Vivos headlines for the 19th of April to make an informed investment decision based on correlating the impacts of news items on Vivos Stock performance. Please note that trading solely based on the Vivos TherapeuticsInc hype is not for everyone as timely availability and quick action are needed to avoid losses.Vivos TherapeuticsInc stock price changes are notoriously difficult to predict based exclusively on its news coverage or social hype. Still, the Vivos earnings-per-share ratio is a good starting point for gauging a company's future prospects. If a firm's EPS rises and meets or even beats consensus forecasts, its shares stand to increase. However, some very sophisticated investors can spot management manipulation of EPS through actions such as buybacks.
Far too much social signal, news, headlines, and media speculation about Vivos TherapeuticsInc that are available to investors today. That information is available publicly through Vivos media outlets and privately through word of mouth or via Vivos internal channels. However, regardless of the origin, that massive amount of Vivos data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Vivos TherapeuticsInc news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Vivos TherapeuticsInc relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Vivos TherapeuticsInc's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Vivos TherapeuticsInc alpha.
Vivos Largest EPS Surprises
Earnings surprises can significantly impact Vivos TherapeuticsInc's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2021-05-17 | 2021-03-31 | -0.17 | -0.19 | -0.02 | 11 | ||
2022-08-15 | 2022-06-30 | -0.25 | -0.28 | -0.03 | 12 | ||
2023-08-16 | 2023-06-30 | -0.14 | -0.18 | -0.04 | 28 | ||
2022-12-20 | 2022-09-30 | -0.28 | -0.33 | -0.05 | 17 | ||
2021-11-15 | 2021-09-30 | -0.18 | -0.26 | -0.08 | 44 | ||
2022-03-31 | 2021-12-31 | -0.25 | -0.34 | -0.09 | 36 |
Vivos TherapeuticsInc Stock Latest Headlines
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using conventional financial analysis. Below is the latest headlines and news related to Vivos TherapeuticsInc Stock. The global stock market is bearish. About 66% of major world exchanges and indexes are down. See today's market update for more information.
15th of April 2024
Reviewing TELA Bio Vivos Therapeutics - Defense World at news.google.com
9th of April 2024
Medicare to reimburse for Vivos CARE sleep apnea devices at seekingalpha.com
1st of April 2024
Vivos Therapeutics, Inc. Q4 2023 Earnings Call Transcript at insidermonkey.com
28th of March 2024
Vivos Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provide... at finance.yahoo.com
14th of March 2024
Short Interest in Vivos Therapeutics, Inc. Declines By 19.2 percent - Defense World at news.google.com
15th of February 2024
Vivos Therapeutics secures 4 million through warrant exercise at investing.com
6th of February 2024
Vivos poised to fill CPAP market gap with FDA-approved devices at investing.com
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Vivos TherapeuticsInc in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Vivos TherapeuticsInc's short interest history, or implied volatility extrapolated from Vivos TherapeuticsInc options trading.
Check out Vivos TherapeuticsInc Backtesting and Vivos TherapeuticsInc Hype Analysis. For more information on how to buy Vivos Stock please use our How to Invest in Vivos TherapeuticsInc guide.You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Complementary Tools for Vivos Stock analysis
When running Vivos TherapeuticsInc's price analysis, check to measure Vivos TherapeuticsInc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vivos TherapeuticsInc is operating at the current time. Most of Vivos TherapeuticsInc's value examination focuses on studying past and present price action to predict the probability of Vivos TherapeuticsInc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vivos TherapeuticsInc's price. Additionally, you may evaluate how the addition of Vivos TherapeuticsInc to your portfolios can decrease your overall portfolio volatility.
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios |
Is Vivos TherapeuticsInc's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Vivos TherapeuticsInc. If investors know Vivos will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Vivos TherapeuticsInc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (11.14) | Revenue Per Share 11.318 | Quarterly Revenue Growth (0.18) | Return On Assets (0.88) | Return On Equity (5.21) |
The market value of Vivos TherapeuticsInc is measured differently than its book value, which is the value of Vivos that is recorded on the company's balance sheet. Investors also form their own opinion of Vivos TherapeuticsInc's value that differs from its market value or its book value, called intrinsic value, which is Vivos TherapeuticsInc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Vivos TherapeuticsInc's market value can be influenced by many factors that don't directly affect Vivos TherapeuticsInc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Vivos TherapeuticsInc's value and its price as these two are different measures arrived at by different means. Investors typically determine if Vivos TherapeuticsInc is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Vivos TherapeuticsInc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.